Drug Discovery Chemistry 2026
Click here for more information: Drug Discovery Chemistry
Venue: Town and Country Resort
Address: 500 Hotel Cir N, San Diego, CA 92108, United States
Our team would be very pleased to meet with you!
Podiums presentation schedule:
Expediting GPCR Fragment Screening: Biophysical Innovation Meets Protein Dynamics
Track: Fragment Based Drug Discovery
Date: Tuesday, April 14
Time: 9:10 AM – 9:40 AM
Presenter: Vanessa Porkolab, PhD, Biophysics Director
Track: Fragment Based Drug Discovery
Date: Tuesday, April 14
Time: 9:10 AM – 9:40 AM
Presenter: Vanessa Porkolab, PhD, Biophysics Director
Accelerating Discovery of Binders and Protein-Protein Interaction Modulators
Track: Protein to Protein Interactions
Date: Thursday, April 16
Time: 12:00 PM – 12:30 PM
Presenter: Jean Bernatchez, PhD, Principal Scientist and R&D Group Leader Vanessa Porkolab, PhD, Biophysics Director
Track: Protein to Protein Interactions
Date: Thursday, April 16
Time: 12:00 PM – 12:30 PM
Presenter: Jean Bernatchez, PhD, Principal Scientist and R&D Group Leader Vanessa Porkolab, PhD, Biophysics Director
Posters presentation schedule:
Discovery of WEE1 Degraders: Integrating Macrocyclic PROTAC Design and High-throughput Molecular Glue Screening
Presenter: Olivier Mirguet, PhD, Global Head of Chemistry
Poster Board Number: P037
Presenter: Olivier Mirguet, PhD, Global Head of Chemistry
Poster Board Number: P037
Characterization of Next-Generation Obesity Therapeutics Using Preclinical and Translational Models
Presenter: Jennifer Wolfe-DeMarco, Senior Scientist
Poster Board Number: P036
Presenter: Jennifer Wolfe-DeMarco, Senior Scientist
Poster Board Number: P036
Integrated High-Throughput Biochemical Binding and Cell-based Targeted Protein Degradation Assay Platforms for STAT
Presenter: Alexander Clifford, PhD, Scientist III R&D
Poster Board Number: P035
Presenter: Alexander Clifford, PhD, Scientist III R&D
Poster Board Number: P035
Expediting GPCR Drug Discovery: Dual Strategy Combining Spectral Shift Screening and Coarse-Grained Molecular Dynamics for A2AR
Presenter: Vanessa Porkolab, PhD, Biophysics Director
Poster Board Number: P038
Presenter: Vanessa Porkolab, PhD, Biophysics Director
Poster Board Number: P038
Comprehensive Analysis of Clinically Discontinued Compounds Using an In Vitro Secondary Pharmacology Panel to Predict Safety Liabilities
Presenter: Danielle Skinner, PhD, Scientist III – Group Leader
Poster Board Number: P039
Presenter: Danielle Skinner, PhD, Scientist III – Group Leader
Poster Board Number: P039
Resources
- LeadHunter STAT SH2 Binding Assays for Cancer, Inflammation and Autoimmune Disease
- Drug Discovery for Anti-Obesity
- High-throughput Spectral Shift: A New Hit Finding Strategy for Binder and Molecular Glue Identification
- Flexible, Proven Chemistry Services Brochure
- Ion Channels Resource Guide
- Safety Pharmacology Resource Guide
- Drug Candidate Assessment Resource Guide
- Delivering Solutions from Discovery to Market Brochure
- Comprehensive Cell-based Assays
- SPRINTer™ Targeted Protein Degradation Assays
- GPCR Cell-based Assays
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
